The global genetic
testing market accounted for USD 3.8 Billion in 2015 and is estimated to reach
USD 4.23 billion in 2016. Growing at a moderately high CAGR of 9.7%, the market
value is expected to reach USD 6.7 billion by 2021.
Some values in the
chart may be randomized. Actual data available on report purchase
In the recent years, with advancements in science and technology, genetic testing has grown to become one of the most important markets in healthcare. Genetic testing allows diagnosis of a disease after its onset, as well as predicting the risk of acquiring a certain disease. There are a number of government initiatives that are being taken to bring about awareness and educate people about the benefits of genetic testing.
In the recent years, with advancements in science and technology, genetic testing has grown to become one of the most important markets in healthcare. Genetic testing allows diagnosis of a disease after its onset, as well as predicting the risk of acquiring a certain disease. There are a number of government initiatives that are being taken to bring about awareness and educate people about the benefits of genetic testing.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/219493 .
Global Genetic
Testing Market- Market Segmentation
The global genetic testing market is segmented by type, disease, technology and geography.
By type, the market is segmented into carrier testing, diagnostic testing, new-born screening, predictive & pre-symptomatic testing and prenatal testing.
The global genetic testing market is segmented by type, disease, technology and geography.
By type, the market is segmented into carrier testing, diagnostic testing, new-born screening, predictive & pre-symptomatic testing and prenatal testing.
The new-born
screening market accounted for the highest market share in 2015 and is
projected to reach USD XX million in 2016 and USD XX billion by 2021, at a CAGR
of XX% during the forecast period. However, the carrier testing market is
expected to grow at the highest CAGR of XX% from 2016 to 2021.
Some values in the
chart may be randomized. Actual data available on report purchase
By disease, the market is segmented into Alzheimer's, cancer, cystic fibrosis, sickle cell anemia, Duchenne's muscular dystrophy, thalassemia, and Huntingtondisease.
By disease, the market is segmented into Alzheimer's, cancer, cystic fibrosis, sickle cell anemia, Duchenne's muscular dystrophy, thalassemia, and Huntingtondisease.
The cancer testing
market holds the largest share and is projected to reach USD XX million in 2016
and USD XX billion by 2021. The Alzheimerdisease testing market holds the
second largest share and is estimated to reach USD XX million in 2016.
Purchase a copy of Global Genetic Testing
Market visit @ http://www.orbisresearch.com/contact/purchase/219493
For more information contact sales@orbisresearch.com .
Some values in the
chart may be randomized. Actual data available on report purchase
By technology, the market is segmented into cytogenetic testing, molecular testing, and biochemical testing markets.
The molecular testing market holds the largest share, estimated to reach USD XX billion in 2016. However, the cytogenetic testing market is expected to grow at the highest CAGR of XX% during the forecast period.
By technology, the market is segmented into cytogenetic testing, molecular testing, and biochemical testing markets.
The molecular testing market holds the largest share, estimated to reach USD XX billion in 2016. However, the cytogenetic testing market is expected to grow at the highest CAGR of XX% during the forecast period.
Some values in the
chart may be randomized. Actual data available on report purchase
By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa and Latin America.
North America accounted for the highest market share and is estimated to reach USD XX billion in 2016. The market in this region is expected to be valued at USD XX billion by 2021, at a CAGR of XX% from 2016 to 2021. The Asia-Pacific market is growing at a CAGR of XX%.
By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa and Latin America.
North America accounted for the highest market share and is estimated to reach USD XX billion in 2016. The market in this region is expected to be valued at USD XX billion by 2021, at a CAGR of XX% from 2016 to 2021. The Asia-Pacific market is growing at a CAGR of XX%.
Some of the key
players in the market are:
Transgenomic, Inc.
23 & Me
Sequenom, Inc.
Abbott Molecular
Biocartis SA
Illumina Inc.
Luminex Corporation
Transgenomic, Inc.
23 & Me
Sequenom, Inc.
Abbott Molecular
Biocartis SA
Illumina Inc.
Luminex Corporation
Get More Information of Global Genetic Testing
Market Report @ http://www.orbisresearch.com/reports/index/global-genetic-testing-market-industry-analysis-and-market-forecast-2017-2022 .
Key Deliverables
in the Study
Market analysis for the genetic testing market, with region-specific assessments and competition analysis on the global and regional scales.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Market analysis for the genetic testing market, with region-specific assessments and competition analysis on the global and regional scales.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively
researched competitive landscape section with profiles of major companies along
with their market share.
Identification and analysis of the macro and micro factors that affect the genetic testing market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the genetic testing market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging
knowledge and insight about the major players in this industry and the key
strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions where this industry is growing and also to identify the regions that are still untapped.
Insights on the major countries/regions where this industry is growing and also to identify the regions that are still untapped.
Some points from List Of Tables:
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
No comments:
Post a Comment